Vima LLC Invests $45,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Vima LLC bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 500 shares of the exchange traded fund’s stock, valued at approximately $45,000.

A number of other large investors have also recently bought and sold shares of XBI. Avoro Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $396,844,000. Healthcare of Ontario Pension Plan Trust Fund grew its position in SPDR S&P Biotech ETF by 35.9% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,406,000 shares of the exchange traded fund’s stock worth $214,832,000 after purchasing an additional 635,000 shares during the period. Phoenix Holdings Ltd. raised its stake in shares of SPDR S&P Biotech ETF by 0.8% during the 3rd quarter. Phoenix Holdings Ltd. now owns 2,151,359 shares of the exchange traded fund’s stock valued at $157,092,000 after buying an additional 17,221 shares during the last quarter. MBB Public Markets I LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 67.0% in the 3rd quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock valued at $37,562,000 after buying an additional 206,337 shares during the period. Finally, Employees Retirement System of Texas purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth about $27,456,000.

SPDR S&P Biotech ETF Price Performance

XBI stock traded down $2.07 during trading on Friday, hitting $91.75. 9,218,504 shares of the company traded hands, compared to its average volume of 10,964,691. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The stock’s 50-day simple moving average is $89.10 and its 200 day simple moving average is $89.75. The company has a market cap of $6.99 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.